- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 17, 2025 | 35.27M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $338.04M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $217.23M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $146.47M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $37.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $285.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $247.69M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $278.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $244.66M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $667.04M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $507.81M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $476.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $330.97M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $957.1M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $759.7M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 36.18M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.12M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.22M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $34.91M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.69M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $45.13M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $81.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $126.33M |